Koers Hemagen Diagnostics, Inc.
Aandelen
HMGN
US4235011057
Medische apparatuur, benodigdheden & distributie
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,000001 USD | -.--% |
|
-.--% | -.--% |
Omzet 2011 | 5,14 mln. 4,75 mln. | Omzet 2012 | 4,04 mln. 3,73 mln. | Marktkapitalisatie | 543K 501K |
---|---|---|---|---|---|
Nettowinst (verlies) 2011 | - 0 | Nettowinst (verlies) 2012 | - 0 | EV/omzet 2011 | 0,97 x |
Nettoschuld 2011 | 4,51 mln. 4,16 mln. | Nettoschuld 2012 | 4,96 mln. 4,58 mln. | EV/omzet 2012 | 1,36 x |
K/w-verhouding 2011 |
-0,5
x | K/w-verhouding 2012 |
-0,58
x | Werknemers | 15 |
Dividendrendement 2011 * |
-
| Dividendrendement 2012 |
-
| Vrij verhandelbaar | 99,36% |
![Extreem 0](/images/extremecours_fleche.png)
![Extreem 0](/images/extremecours_fleche.png)
![Extreem 0](/images/extremecours_fleche.png)
![Extreem 0](/images/extremecours_fleche.png)
Managers | Titel | Leeftijd | Van |
---|---|---|---|
William Hales
CEO | Chief Executive Officer | 61 | 01-10-99 |
M. Campbell
DFI | Director of Finance/CFO | 54 | 09-01-13 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
William Hales
CEO | Chief Executive Officer | 61 | 01-10-99 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-.--% | 15 | |
-6,61% | 11,96 mld. | |
-19,37% | 6,6 mld. | |
+6,63% | 5,75 mld. | |
+26,89% | 5,51 mld. | |
-21,19% | 3,48 mld. | |
+6,64% | 2,51 mld. | |
+30,09% | 2,26 mld. | |
-66,69% | 2,24 mld. | |
-12,28% | 2,19 mld. |